Heparanase upregulation by colonic epithelium in inflammatory bowel disease

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Modern Pathology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/modpathol.3800710PMID 17041566
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities

  2006cited by this paper
• Role of endothelial heparanase in delayed-type hypersensitivity.

  2006cited by this paper
• Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence

  2006cited by this paper
• Heparanase expression correlates with malignant potential in human colon cancer

  2005cited by this paper
• New Concepts in the Pathophysiology of Inflammatory Bowel Disease

  2005cited by this paper
• Processing and activation of latent heparanase occurs in lysosomes

  2004cited by this paper
• The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation.

  2004cited by this paper
• Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.

  2004cited by this paper
• The immunological and genetic basis of inflammatory bowel disease

  2003cited by this paper
• Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells.

  2003cited by this paper
• Heterodimer formation is essential for heparanase enzymatic activity.

  2003cited by this paper
• Activation, processing and trafficking of extracellular heparanase by primary human fibroblasts.

  2002cited by this paper
• Human heparanase is localized within lysosomes in a stable form.

  2002cited by this paper
• Successful treatment of an acute flare of steroid-resistant Crohn's colitis during pregnancy with unfractionated heparin.

  2002cited by this paper
• Low-Dose Low-Molecular Weight Heparin (Enoxaparin) Is Effective as Adjuvant Treatment in Active Ulcerative Colitis: An Open Trial

  2001cited by this paper
• Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

  2001cited by this paper
• Heparanase: a key enzyme involved in cell invasion.

  2001cited by this paper
• Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis.

  2000cited by this paper
• A Simple Classification of Crohn's Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998

  2000cited by this paper
• Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation

  2000cited by this paper
• Heparanase, a potential regulator of cell-matrix interactions.

  2000cited by this paper
• Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease

  1999cited by this paper
• Functions of cell surface heparan sulfate proteoglycans.

  1999cited by this paper
• Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides

  1999cited by this paper
• Treatment of central nervous system inflammation with inhibitors of basement membrane degradation

  1998cited by this paper
• Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils.

  1997cited by this paper
• Comparative analysis of the ability of leucocytes, endothelial cells and platelets to degrade the subendothelial basement membrane: Evidence for cytokine dependence and detection of a novel sulfatase

  1995cited by this paper
• Inhibition of tumor metastasis by heparanase inhibiting species of heparin.

  1994cited by this paper
• Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.

  1992cited by this paper
• Proteoglycans: structures and interactions.

  1991cited by this paper
• Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins.

  1989cited by this paper
• Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules.

  1989cited by this paper
• Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species.

  1987cited by this paper
• Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes.

  1985cited by this paper
• Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase

  1984cited by this paper
• Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase.

  1984cited by this paper
• Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis.

  1983cited by this paper
• Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines.

  1983cited by this paper

• Identification of potential diagnostic markers and molecular mechanisms of asthma and ulcerative colitis based on bioinformatics and machine learning

  2025cites this paper
• Endothelial glycocalyx damage is associated with small intestinal disease in horses.

  2025cites this paper
• Heparan Sulfate Proteoglycans (HSPGs) and Their Degradation in Health and Disease

  2025cites this paper
• The Uptake of Heparanase into Mast Cells Is Regulated by Its Enzymatic Activity to Degrade Heparan Sulfate

  2024cites this paper
• Exploring Heparanase Levels in Tears: Insights From Herpes Simplex Virus-1 Keratitis Patients and Animal Studies

  2024cites this paper
• Natural products with anti-tumorigenesis potential targeting macrophage.

  2024cites this paper
• Identification of COL3A1 as a candidate protein involved in the crosstalk between obesity and diarrhea using quantitative proteomics and machine learning.

  2024cites this paper
• The novel HS-mimetic, Tet-29, regulates immune cell trafficking across barriers of the CNS during inflammation

  2023cites this paper
• Design of an Ultralow Molecular Weight Heparin That Resists Heparanase Biodegradation.

  2023cites this paper
• Role of heparanase in ARDS through autophagy and exosome pathway (review)

  2023cites this paper
• Evaluation of Immunohistochemical Expression of Heparanase in Helicobacter pylori-Associated Chronic Gastritis

  2023cites this paper
• Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft‐versus‐host disease after allogeneic stem cell transplant

  2023cites this paper
• Computational design and experimental characterisation of a stable human heparanase variant

  2022cites this paper
• Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis

  2022cites this paper
• Inflammatory Bowel Disease-Associated Gut Commensals Degrade Components of the Extracellular Matrix

  2022cites this paper
• Parabacteroides produces acetate to alleviate heparanase-exacerbated acute pancreatitis through reducing neutrophil infiltration

  2021cites this paper
• Immunohistochemical Expression of Heparanase-2 in Psoriasis

  2021cites this paper
• Helicobacter pylori-Induced Heparanase Promotes H. pylori Colonization and Gastritis

  2021cites this paper
• Involvement of Syndecan-1 and Heparanase in Cancer and Inflammation.

  2020cites this paper
• Role of Heparanase in tumor progression: molecular aspects and therapeutic options.

  2020cites this paper
• Glycosylation changes in inflammatory diseases.

  2020cites this paper
• Role of Heparanase in Macrophage Activation.

  2020cites this paper
• Heparanase and the hallmarks of cancer

  2020cites this paper
• Effect of heparanase inhibitor on tissue factor overexpression in platelets and endothelial cells induced by anti‐β2‐GPI antibodies

  2020cites this paper
• Distinct extracellular-matrix remodeling events precede symptoms of inflammation.

  2020cites this paper
• Upregulation of Fecal Epithelial Heparanase mRNA Is Associated with Increased Ulcerative Colitis Activity and Cancerization Risk

  2020cites this paper
• Leukocyte Heparanase: A Double-Edged Sword in Tumor Progression

  2019cites this paper
• Title: Multidimensional extracellular-matrix analysis reveals a silent pre-clinical signature in inflammatory disease

  2019cites this paper
• Unraveling the state-specific nature of the native extracellular matrix via multidimensional characterization of its material properties

  2019cites this paper
• Prophylactic Antiheparanase Activity by PG545 Is Antiviral In Vitro and Protects against Ross River Virus Disease in Mice

  2018cites this paper
• The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies

  2018cites this paper
• Effect of Polarization and Chronic Inflammation on Macrophage Expression of Heparan Sulfate Proteoglycans and Biosynthesis Enzymes

  2018cites this paper
• Non-anticoagulant effects of low molecular weight heparins in inflammatory disorders: A review.

  2017cites this paper
• Heparanase and macrophage interplay in the onset of liver fibrosis

  2017cites this paper
• Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy

  2017cites this paper
• Heparanase Mediates Intestinal Inflammation and Injury in a Mouse Model of Sepsis

  2017cites this paper
• HER-2/neu Overxpression in Esophageal Squamous Cell Carcinoma (ESCC) and Its Correlation with Patient’s Clinicopathological Features

  2016cites this paper
• Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases.

  2016cites this paper
• Old and new applications of non-anticoagulant heparin.

  2016cites this paper
• Heparins and fucoidans : future therapeutic options for ulcerative colitis

  2016cites this paper
• Heparanase: From basic research to therapeutic applications in cancer and inflammation.

  2016influential citation
• Experimental evidence of heparanase, Hsp70 and NF-κB gene expression on the response of anti-inflammatory drugs in TNBS-induced colonic inflammation.

  2015cites this paper
• The Role of Heparanase in Pulmonary Cell Recruitment in Response to an Allergic but Not Non-Allergic Stimulus

  2015cites this paper
• Involvement of Heparanase in Empyema: Implication for Novel Therapeutic Approaches.

  2015cites this paper
• Mechanisms of Renal Graft Chronic Injury and Progression to Interstitial Fibrosis

  2015cites this paper
• Heparins in ulcerative colitis: proposed mechanisms of action and potential reasons for inconsistent clinical outcomes

  2015cites this paper
• Soluble Heparan Sulfate Fragments Generated by Heparanase Trigger the Release of Pro-Inflammatory Cytokines through TLR-4

  2014cites this paper
• Heparanase is preferentially expressed in human psoriatic lesions and induces development of psoriasiform skin inflammation in mice

  2014cites this paper
• Macrophage polarization in pancreatic carcinoma: role of heparanase enzyme.

  2014cites this paper
• Mice deficient in heparanase exhibit impaired dendritic cell migration and reduced airway inflammation

  2014cites this paper
• ECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammation

  2014cites this paper
• Heparanase as a target in cancer therapy.

  2014cites this paper
• Efeitos do extrato de Baccharis dracunculifolia DC em diferentes mediadores da inflamação intestinal induzida por TNBS em ratos

  2013cites this paper
• A fluorescent spectroscopy and modelling analysis of anti-heparanase aptamers-serum protein interactions.

  2013cites this paper
• Low Molecular Weight Heparin Relieves Experimental Colitis in Mice by Downregulating IL-1β and Inhibiting Syndecan-1 Shedding in the Intestinal Mucosa

  2013cites this paper
• Versatile role of heparanase in inflammation.

  2013influential citation
• The function of heparanase in diabetes and its complications.

  2013cites this paper
• Heparanase in inflammation and inflammation‐associated cancer

  2013cites this paper
• Heparanase and Autoimmune Diabetes

  2013cites this paper
• Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses

  2013influential citation
• Molecular characterization, expression profiles, and association analysis with hematologic parameters of the porcine HPSE and HPSE2 genes

  2012cites this paper
• Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance.

  2012cites this paper
• Significance of Heparanase in Cancer and Inflammation

  2012cites this paper
• Insights into targeting colon cancer cell fate at the level of proteoglycans / glycosaminoglycans.

  2012cites this paper
• Metabolic Reconstruction for Metagenomic Data and Its Application to the Human Microbiome

  2012cites this paper
• Enoxaparin Treatment for Vulvodynia: A Randomized Controlled Trial

  2012cites this paper
• Heparanase enzyme in chronic inflammatory bowel disease and colon cancer

  2012influential citation
• Impact of Heparanase and the Tumor Microenvironment on Cancer Metastasis and Angiogenesis: Basic Aspects and Clinical Applications

  2011cites this paper
• Universidade Estadual Paulista Instituto de Biociências Campus de Botucatu HSP70, Heparanase e HPRT participam da resposta inflamatória intestinal induzida por TNBS em ratos.

  2011cites this paper
• Heparanase expression in term placentas of diabetic patients and healthy controls

  2011cites this paper
• Influence of heparan sulfate chains in proteoglycan at the dermal–epidermal junction on epidermal homeostasis

  2011cites this paper
• Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice.

  2011cites this paper
• Biomarkers in chronic graft-versus-host disease

  2011cites this paper
• Activated Syndecan-1 Shedding Contributes to Mice Colitis Induced by Dextran Sulfate Sodium

  2011cites this paper
• Sulfated hexasaccharides attenuate metastasis by inhibition of P-selectin and heparanase.

  2011cites this paper
• Heparanase expression in periapical granulomas and radicular cysts

  2011cites this paper
• CB-01-05-MMX, a novel oral controlled-release low molecular weight heparin for the potential treatment of ulcerative colitis.

  2010cites this paper
• Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors.

  2010cites this paper
• Expression of heparanase: a possible role in invasiveness and aggressive clinical behavior of ameloblastomas.

  2010influential citation
• Chronic Cyclooxygenase-2 Inhibition Promotes Myofibroblast-Associated Intestinal Fibrosis

  2010cites this paper
• Tumorigenic and adhesive properties of heparanase.

  2010cites this paper
• DAMPening Inflammation by Modulating TLR Signalling

  2010cites this paper
• Heparin, heparan sulfate and heparanase in inflammatory reactions

  2009cites this paper
• Inverse correlation between HPSE gene single nucleotide polymorphisms and heparanase expression: possibility of multiple levels of heparanase regulation

  2009cites this paper
• Heparanase expression by Barrett's epithelium and during esophageal carcinoma progression

  2009cites this paper
• Up-Regulation of Heparanase in the Ethmoid Sinus Mucosa of Patients with Chronic Sinusitis

  2009cites this paper
• Anti‐heparanase monoclonal antibody enhances heparanase enzymatic activity and facilitates wound healing

  2007cites this paper